Screening for Hepatitis B and Hepatitis C is recommended for individuals who fall into specific high risk categories or have a history of potential exposure to infected blood or bodily fluids. Because these viral infections often remain asymptomatic for many years, proactive testing is the only reliable method for identifying the virus before it causes significant liver damage. In the United Kingdom, healthcare providers use targeted screening to identify those who may benefit from modern antiviral treatments or vaccination. Identifying an infection early allows for clinical monitoring that can prevent long term complications such as cirrhosis or liver cancer.
What We’ll Discuss in This Article
- Groups at higher risk of Hepatitis B and C exposure in the UK.
- The importance of screening based on country of origin.
- Historical medical factors, including blood transfusions before 1991.
- Risks associated with lifestyle factors and medical procedures abroad.
- Screening recommendations for pregnant women and household contacts.
- How to access confidential testing through the NHS.
Primary Groups for Hepatitis B Screening
Hepatitis B screening is essential for individuals born in parts of the world where the virus is common, as well as those with specific lifestyle or occupational risks. The NHS recommends Hepatitis B testing for people born in high prevalence regions, including South Asia, East Asia, Sub-Saharan Africa, and parts of Eastern Europe. In these areas, the virus is often passed from mother to child during birth or through close contact during early childhood.
Other groups prioritised for screening include people who have ever injected drugs, men who have sex with men, and individuals who have changed sexual partners frequently without using barrier protection. Healthcare workers and laboratory staff who may come into contact with blood or bodily fluids are also routinely screened to ensure workplace safety. Additionally, anyone living in a household with a person known to have Hepatitis B should be tested to determine if they require vaccination or treatment.
Priority Groups for Hepatitis C Screening
Hepatitis C screening focuses primarily on individuals who may have been exposed to infected blood through medical procedures, non-sterile equipment, or shared needles. NICE clinical guidelines state that anyone who has ever injected drugs, even if only once many years ago, should be offered a Hepatitis C test. This remains the most common route of transmission in the UK.
Screening is also recommended for individuals who have received medical or dental treatment in countries where infection control practices may be less stringent. This includes routine vaccinations, surgical procedures, or blood transfusions performed in regions with high Hepatitis C prevalence. Because the virus is highly resilient, it can survive on equipment that has not been professionally sterilised, making it possible to contract the virus during seemingly minor clinical or cosmetic procedures performed in unregulated environments.
Historical Medical Factors and Transfusions
Individuals who received blood transfusions or blood products in the UK prior to September 1991 are a key group for Hepatitis C screening. Before this date, the UK blood supply was not routinely screened for the Hepatitis C virus, as the technology to do so was not yet available. Many people were unknowingly infected during this period and may still be carrying the virus without showing any symptoms.
The UK government health services actively encourage anyone who received blood, a transplant, or tissue in the UK before 1991 to seek a one-off Hepatitis C test. This also applies to those who received treatment for conditions like haemophilia during that era. Identifying these historical infections is a major public health priority, as modern direct-acting antiviral medications can now cure over 95 percent of cases, preventing the need for future liver transplants.
Screening During Pregnancy and for Family Contacts
In the UK, all pregnant women are offered screening for Hepatitis B as part of their routine antenatal care. This is a vital preventive measure because a mother with Hepatitis B can pass the virus to her baby during birth. Identifying the mother’s status allows the clinical team to administer a vaccination and sometimes an immunoglobulin injection to the newborn immediately after delivery, which is highly effective at preventing the child from developing a chronic infection.
Screening is also highly recommended for the family members and sexual partners of anyone diagnosed with Hepatitis B or C. Hepatitis B is significantly more infectious than Hepatitis C and can be spread through close household contact, such as sharing razors or toothbrushes. Testing household contacts ensures that they can be protected through the Hepatitis B vaccine if they are not already immune, while testing partners of those with Hepatitis C allows for clear communication regarding transmission risks.
Lifestyle and Cosmetic Procedure Risks
Individuals who have engaged in certain lifestyle activities or received cosmetic treatments using non-sterile equipment should consider being screened for both viruses. This includes having a tattoo or body piercing in an unregulated setting or in a country where equipment is reused without medical-grade sterilisation. While modern UK tattoo studios follow strict hygiene laws, older tattoos or those done abroad may have posed a risk.
| Risk Factor | Recommended Action | Primary Virus of Concern |
| Injecting Drugs (past or present) | Seek screening | Hepatitis C and B |
| UK Blood Transfusion (Pre-1991) | Seek screening | Hepatitis C |
| Born in High Prevalence Region | Seek screening | Hepatitis B |
| Pregnant Women | Routine screening offered | Hepatitis B |
| Unregulated Tattoos / Piercings | Consider screening | Hepatitis C and B |
Sharing personal items that may have trace amounts of blood, such as razors, toothbrushes, or equipment used for intranasal drug use, also warrants a discussion about screening. Although the risk from these activities is lower than from direct blood-to-blood contact, they are recognised potential routes for viral transmission.
Conclusion
Screening for Hepatitis B and C is a targeted process aimed at individuals with historical, medical, or lifestyle risk factors. Whether due to birth in a high-prevalence country, medical treatment before 1991, or past lifestyle choices, proactive testing is the only way to identify these often silent infections. Accessing testing through the NHS is a straightforward step that can lead to life-saving treatment and prevent the spread of the virus to others. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
If I feel healthy, do I still need a test?
Yes, because both viruses can cause progressive liver damage for decades without making a person feel ill until the damage is advanced.
Is the screening test different for Hepatitis B and C?
Yes, they are separate blood tests; one looks for Hepatitis B antigens and the other for Hepatitis C antibodies.
Can I be screened anonymously?
Most sexual health clinics offer confidential and sometimes anonymous testing for blood-borne viruses.
What if I was vaccinated for Hepatitis B as a child?
If you were fully vaccinated, you should be immune, but if you were born in a high-risk area before vaccination, you may still need a baseline test.
Do I need to be screened for Hepatitis C every year?
Annual screening is only recommended if you have ongoing risk factors, such as current drug use or being on a specialist clinical pathway.
Can a tattoo from a high-street shop in the UK give me Hepatitis?
The risk is extremely low in regulated UK shops as they must follow strict local authority health and safety laws.
Will my GP charge me for these tests?
No, screening for Hepatitis B and C for those at risk is provided free of charge by the NHS.
Authority Snapshot (E-E-A-T)
This article provides medically factual health information regarding viral hepatitis screening, strictly aligned with NHS and NICE clinical guidelines. The content is developed by a medical writing team and reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. All information follows current UK public health protocols to ensure patient safety and clinical accuracy.
